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Background
During the last decade research has focused on the
application of FOXP3
+ regulatory T cells (Treg) in the
treatment of autoimmune disease. However, thorough
functional characterization of these cells in patients with
chronic autoimmune disease, especially at the site of
inflammation, is still missing.
Aim
Here we studied Treg function at the site of autoim-
mune inflammation in patients with juvenile idiopathic
arthritis (JIA).
Methods
Mononuclear cells were isolated from peripheral blood
(PB) of both patients and healthy controls (HC) and
from synovial fluid of JIA patients. To study Treg func-
tion, in vitro suppression assays were performed mea-
suring both T cell proliferation and cytokine production
in the culture supernatant. In addition, responsiveness
to TGFb mediated suppression was investigated by cul-
turing effector cells in the presence of TGFb.
Results
Treg from both the peripheral blood as well as the
inflamed joints of JIA patients were fully functional.
Nevertheless, Treg-mediated suppression of cell prolif-
eration and cytokine production by effector cells from
the site of inflammation was severely impaired, due to
resistance to suppression. In these inflammatory effector
cells, activation of protein kinase B (PKB)/c-akt was
enhanced and inhibition of this kinase restored respon-
siveness to suppression.
Conclusions
PKB/c-akt hyperactivation causes resistance of effector
cells to suppression at the site of inflammation in
human autoimmune disease. These findings suggest that
for a Treg enhancing strategy to be successful in the
treatment of autoimmune inflammation, resistance of
effector cells to suppression should be targeted as well.
This might be achieved by selectively inhibiting PKB/c-
akt activation.
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